ValeurQ4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26TTMFrais de vente, généraux et administratifs2.12 B2.3 B2.08 B2.04 B2.23 B2.28 B8.63 BRecherche et développement358 M405 M407 M410 M401 M413 M1.63 BRésultat d'exploitation581 M837 M1.11 B1.14 B1.8 B936 M4.99 BTotal des produits hors exploitation-53 M-73 M-97 M-106 M371 M62 M230 MCharges d'intérêts, nettes des intérêts capitalisés104 M137 M159 M157 M129 M148 M593 MRésultat hors exploitation, hors charges d'intérêts-53 M-73 M-256 M-263 M242 M-86 M-363 MRevenus/dépenses exceptionnels———————Résultat avant impôts528 M764 M1.02 B1.03 B1.71 B850 M4.6 BPart des actionnaires dans le résultat———————Impôts-18 M110 M132 M170 M856 M105 M1.26 BIntérêts ne donnant pas le contrôle / intérêts minoritaires———————Autres produits/charges après impôts———————Résultat net avant activités abandonnées546 M654 M884 M859 M849 M745 M3.34 BActivités abandonnées———————Résultat net546 M654 M884 M859 M849 M745 M3.34 BAjustement de dilution———————Dividendes privilégiés———————Résultat net dilué revenant aux actionnaires ordinaires546 M654 M884 M859 M849 M745 M3.34 BBénéfice par action de base (BPA de base)1.431.712.322.252.211.958.73Bénéfice par action dilué (BPA dilué)1.411.692.292.222.21.938.64Nombre moyen d'actions de base en circulation381 M381.7 M382.2 M382.4 M382.2 M382.9 M—Nombre d'actions en circulation après dilution385.6 M386.4 M386.4 M386.7 M386.5 M386.5 M—EBITDA927 M1.2 B1.5 B1.54 B2.22 B1.33 B6.59 BEBIT581 M837 M1.11 B1.14 B1.8 B936 M4.99 BCoût des ventes2.26 B2.12 B2.18 B2.21 B2.54 B2.21 B9.14 BAutres coûts des ventes———————Amortissements (flux de trésorerie)346 M361 M389 M404 M416 M397 M1.61 B
Stryker Corporation Common Stock
Stryker Corporation is an American multinational medical technologies corporation based in Portage, Michigan, United States. The company's products are used for medical surgery and neurotechnology, which include surgical equipment, patient and caregiver safety technologies, endoscopy systems, and patient handling, emergency medical equipment, and intensive care disposable products, as well as neurosurgical, neurovascular and oral and maxillofacial surgery implant products; and orthopedic surgery, which includes implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. Stryker's products are sold in over 75 countries and are used by 150 million patients annually. In 2024, 75% of the company's revenues came from the United States.
The company is ranked 195th on the Fortune 500 and 331st on the Forbes Global 2000.